Fidelity Investments’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Fidelity Investments's PALI Position: Q3 2026 in Review
Fidelity Investments increased its Palisade Bio (PALI) stake by 229% in Q3 2026, buying an estimated $2.46K and bringing the position to 1,813 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #5194.
Fidelity Investments first reported a position in PALI in Q3 2022 and has held it in 5 quarters since. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Fidelity Investments held 1,813 shares of Palisade Bio worth $2.45K as of Q3 2026.
- Fidelity Investments bought 1,262 Palisade Bio shares in Q3 2026, an estimated $2.46K.
- Palisade Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5194 holding.
- Fidelity Investments first reported a position in Palisade Bio in Q3 2022 and has held it in 5 quarters since.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.